Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $22.75 Average Target Price from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been assigned a consensus rating of “Hold” from the fifteen ratings firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $18.8182.

Several brokerages have recently weighed in on ACHC. Leerink Partners restated a “market perform” rating and set a $14.00 price objective (down previously from $25.00) on shares of Acadia Healthcare in a research report on Wednesday, December 3rd. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a research report on Wednesday, December 3rd. Royal Bank Of Canada dropped their price objective on Acadia Healthcare from $22.00 to $19.00 and set an “outperform” rating on the stock in a report on Wednesday, December 3rd. Cantor Fitzgerald set a $17.00 target price on Acadia Healthcare in a research report on Wednesday, December 3rd. Finally, Leerink Partnrs cut Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 3rd.

Institutional Trading of Acadia Healthcare

A number of large investors have recently bought and sold shares of the business. Allworth Financial LP increased its stake in Acadia Healthcare by 676.4% in the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after purchasing an additional 1,177 shares during the period. EverSource Wealth Advisors LLC raised its stake in Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the last quarter. Hantz Financial Services Inc. lifted its position in Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after acquiring an additional 1,822 shares during the period. CWM LLC grew its stake in shares of Acadia Healthcare by 105.1% in the 2nd quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after purchasing an additional 1,349 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after purchasing an additional 2,698 shares during the period.

Acadia Healthcare Trading Down 2.2%

NASDAQ:ACHC opened at $13.23 on Tuesday. Acadia Healthcare has a 1 year low of $12.63 and a 1 year high of $47.08. The stock has a market cap of $1.22 billion, a P/E ratio of 11.31, a P/E/G ratio of 3.55 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44. The stock has a 50-day simple moving average of $15.44 and a 200-day simple moving average of $20.23.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.01. The business had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The business’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the company earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.